Molecular Formula | C14H21N3O2S |
Molar Mass | 295.4 |
Density | 1.1778 (rough estimate) |
Melting Point | 169-171°C |
Boling Point | 497.7±55.0 °C(Predicted) |
Flash Point | 265.5°C |
Water Solubility | 21.4 mg/mL |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Vapor Presure | 9.95E-11mmHg at 25°C |
Appearance | Solid |
Color | Off-White to Pale Yellow |
pKa | pKa 9.5 (Uncertain) |
Storage Condition | Refrigerator |
Refractive Index | 1.6740 (estimate) |
Physical and Chemical Properties | White crystalline powder, soluble in water. The melting point was 169-171 °c. Sumatriptan sucinate: C14H21N302S? C4H504. [103628-48-4]. The melting point was 165-166 °c. |
Use | Used as a migraine treatment |
Hazard Symbols | Xi - Irritant![]() |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
WGK Germany | 3 |
HS Code | 2935904000 |
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
product features | sumatretan, as an anti-migraine drug, is a highly selective serotonin receptor (5-HT1B/1D) agonist, which reverses the intracranial vasodilation during migraine, reduces plasma protein extravasation, thereby improving cerebral blood flow and relieving migraine symptoms. |
Use | is a serotonin receptor active drug, and the main mode of action is to selectively contract the cranial blood vessels. For migraine. Used as migraine medicine |
production method | the following nitriles are hydrogenated at room temperature for 24h under 10% palladium-carbon catalysis in methanol solution of dimethylamine to obtain sumataptan. |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |